Lightlake Therapeutics Is Developing A New Treatment For Bulimia
Links shared publicly online about this topic.
- 279total visits
Lightlake Therapeutics Is Developing A New Treatment For Bulimia
Lightlake Therapeutics Inc. (OTC.BB.-LLTP), the specialist biopharma company, is extending the range of its research into effective treatments for eating disorders to bulimia and amphetamine, coca
View full resource at medicalnewstoday.com
Tags: Eating Disorder, Bulimia, Disease and Condition, Adderall
Most Recently Shared on May 20, 2011 at 12:05 pm By:
Lightlake Therapeutics Is Developing A New Treatment For Bulimia http://mnt.to/3W94 #eatingdisorders
Lightlake to begin opioid antagonist derived nasal spray Phase II trials in Binge Eating Disorder
news-medical.net — “Lightlake Therapeutics Inc., an early stage biopharmaceutical company currently developing a nasal spray for the treatment of overweight and obese patients with Binge Eating Disorder, today announced that its patient testing stage of the Phase II clinical trials will start August 26th, 2011” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 6:30 am By:
Lightlake to begin opioid antagonist derived nasal spray Phase II trials in Binge Eating Disorder: Lightlake The... http://t.co/9gQuyJ5
Advertisement
